Have a personal or library account? Click to login
Homeostasis Regulating Factors, Innervation, Ischemia and Inflammatory Markers in the Right Atrial Tissue from Patients with Degenerative Aortic Valve Stenosis and Coronary Heart Disease Cover

Homeostasis Regulating Factors, Innervation, Ischemia and Inflammatory Markers in the Right Atrial Tissue from Patients with Degenerative Aortic Valve Stenosis and Coronary Heart Disease

Open Access
|Jul 2021

References

  1. Agmon, Y., Khandheria, B. K., Meissner, I., Sicks, J. R. D., O’Fallon, W. M., Wiebers, D. O., Whisnant, J. P., Seward, J. B., Tajik, A. J. (2001). Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study. J. Amer. Coll. Cardiol., 38 (3), 827–834.10.1016/S0735-1097(01)01422-X
  2. Akahori, H., Tsujino, T., Masuyama, T., Ishihara, M. (2018). Mechanisms of aortic stenosis. J. Cardiol., 71 (3), 215–220.10.1016/j.jjcc.2017.11.00729258711
  3. Allison, M. A., Cheung, P., Criqui, M. H., Langer, R. D., Wright, C. M. (2006). Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation, 113 (6), 861–866.10.1161/CIRCULATIONAHA.105.55284416461818
  4. Angelone, T., Mazza, R., C. Cerra, M. (2012). Chromogranin-A: A multifaceted cardiovascular role in health and disease. Curr. Med. Chem., 19 (24), 4042–4050.10.2174/09298671280243000922834795
  5. Bakerman, I., Mirwais, W., Nguyen, P. (2018). Molecular imaging of inflammation in ischemic heart disease. Curr. Cardiovasc. Imaging Rep., 11 (6), 13.
  6. Baumgartner, H., Walther, T. (2018). Aortic stenosis. In: The ESC Textbook of Cardiovascular Medicine. 3rd ed. https://doi.org/10.1093/med/9780198784906.001.0001 (accessed 10.05.2021).10.1093/med/9780198784906.001.0001
  7. Bonetti, P. O., Lerman, L. O., Lerman, A. (2003). Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol., 23 (2), 168–175.10.1161/01.ATV.0000051384.43104.FC
  8. Ceconi, C., Ferrari, R., Bachetti, T., Opasich, C., Volterrani, M., Colombo, B., Parinello, G., Corti, A. (2002). Chromogranin A in heart failure: A novel neurohumoral factor and a predictor for mortality. Eur. Heart J., 23 (12), 967–974.10.1053/euhj.2001.297712069452
  9. Chow, C. T. L., Chow, M. S. S., Anderson, R. H., Gosling, J. A. (2001). Autonomic innervation of human cardiac conduction system: Changes from infancy to senility — an immunohistochemical and histochemical analysis. Anat. Rec., 264 (2), 169–182.10.1002/ar.115811590594
  10. Cihakova, D. (2018). Interleukin-10 stiffens the heart. J. Exper. Med., 215 (2), 379.10.1084/jem.20180049578942329348198
  11. Daka, B., Olausson, J., Larsson, C. A., Hellgren, M. I., Råstam, L., Jansson, P. A., Lindblad, U. (2015). Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: A longitudinal observational study in the Vara-Skövde Cohort. BMC Cardiovasc. Disord., 15, 146.10.1186/s12872-015-0141-y464727526573599
  12. Dashkevich, A., Lemström, K. B., Nykänen, A. I. (2013). VEGF receptor signaling in the cardiac lymphatics. In: The Cardiac Lymphatic System, pp. 125–143. https://link.springer.com/chapter/10.1007/978-1-4614-6774-8_9 (accessed 10.05.2021).
  13. Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Webb, D. J., Maguire, J. J. (2016). Endothelin. Pharmacol. Rev., 68 (2), 357–418.10.1124/pr.115.011833
  14. Dhople, V., Krukemeyer, A., Ramamoorthy, A. (2006). The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochimica et Biophysica Acta - Biomembranes, 1758 (9), 1499–1512.10.1016/j.bbamem.2006.07.007
  15. Di Paolo, N. C., Shayakhmetov, D. M. (2016). Interleukin 1α and the inflammatory process. Nature Immunol., 17 (8), 906–913.10.1038/ni.3503
  16. Goel, S. S., Ige, M., Tuzcu, E. M., Ellis, S. G., Stewart, W. J., Svensson, L. G., Lytle, B. W., Kapadia, S. R. (2013). Severe aortic stenosis and coronary artery disease — implications for management in the transcatheter aortic valve replacement era: A comprehensive review. J. Amer. Coll. Cardiol., 62 (1), 1–10.10.1016/j.jacc.2013.01.096
  17. Goetze, J. P., Alehagen, U., Flyvbjerg, A., Rehfeld, J. F. (2013). Making sense of chromogranin A in heart disease. The Lancet Diabetes and Endocrinology, 1 (1), 7–8.10.1016/S2213-8587(13)70035-4
  18. Goetze, J. P., Christoffersen, C., Perko, M., Arendrup, H., Rehfeld, J. F., Kastrup, J., Nielsen, L. B. (2003). Increased cardiac BNP expression associated with myocardial ischemia. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 17 (9), 1105–1107.10.1096/fj.02-0796fje
  19. Huang, W., Boyle, N., Vaseghi, M. (2017). Cardiac innervation and the autonomic nervous system in SCD. Card. Electrophysiol. Clin., 9 (4), 665–679.10.1016/j.ccep.2017.08.002
  20. Hulsmans, M., Sager, H. B., Roh, J. D., Valero-Muńoz, M., Houstis, N. E., Iwamoto, Y., Sun, Y., Wilson, R. M., Wojtkiewicz, G., Tricot, B., et al. (2018). Cardiac macrophages promote diastolic dysfunction. J. Exper. Med., 215 (2), 423–440.10.1084/jem.20171274
  21. Isner, J. M., Chokshi, S. K., Defranco, A., Braimen, J., Slovenkai, G. A. (1990). Contrasting histoarchitecture of calcified leaflets from stenotic bicuspid versus stenotic tricuspid aortic valves. J. Amer. Coll. Cardiol., 15 (5), 1104–1108.10.1016/0735-1097(90)90249-O
  22. Iung, B., Baron, G., Butchart, E. G., Delahaye, F., Gohlke-Bärwolf, C., Levang, O. W., Tornos, P., Vanoverschelde, J. L., Vermeer, F., Boersma, E., Ravaud, P., Vahanian, A. (2003). A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J., 24 (13), 1231–1243.10.1016/S0195-668X(03)00201-X
  23. Jeong, D. S., Sung, K., Kim, W. S., Lee, Y. T. (2014). Fate of functional tricuspid regurgitation in aortic stenosis after aortic valve replacement. J. Thorac. Cardiovasc. Surg., 148 (4), 1328–1333.10.1016/j.jtcvs.2013.10.05624332115
  24. Kanwar, A., Thaden, J. J., Nkomo, V. T. (2018). Management of patients with aortic valve stenosis. Mayo Clinic Proc., 93 (4), 488–508.10.1016/j.mayocp.2018.01.02029622096
  25. Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., Pibarot, P. (2016). Calcific aortic stenosis. Nat. Rev. Dis. Primers, 2, 16006.10.1038/nrdp.2016.6512728627188578
  26. Maeda, S., Tanabe, T., Miyauchi, T., Otsuki, T., Sugawara, J., Iemitsu, M., Kuno, S., Ajisaka, R., Yamaguchi, I., Matsuda, M. (2003). Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J. Appl. Physiol., 95 (1), 336–341.10.1152/japplphysiol.01016.200212611765
  27. Mann, D. (2012). Pathophysiology of heart failure. In: Publication Veterinary Continuing Education, Massey University, pp. 1–26.10.1016/B978-1-4377-0398-6.00025-1
  28. Molenaar, P., O’Reilly, G., Sharkey, A., Kuc, R. E., Harding, D. P., Plump-ton, C., Gresham, G. A., Davenport, A. P. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circul. Res., 72 (3), 526–538.10.1161/01.RES.72.3.5267679333
  29. Mosser, D. M., Zhang, X. (2008). Interleukin-10: New perspectives on an old cytokine. Immunol. Rev., 226, 205–218.10.1111/j.1600-065X.2008.00706.x272498219161426
  30. Nakagawa, Y., Nishikimi, T., Kuwahara, K. (2019). Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides, 111, 18–25.10.1016/j.peptides.2018.05.01229859763
  31. Novo, G., Sansone, A., Rizzo, M., Guarneri, F., Pernice, C., Novo, S. (2014). High plasma levels of endothelin-1 enhance the predictive value of preclinical atherosclerosis for future cerebrovascular and cardiovascular events: A 20-year prospective study. J. Cardiovasc. Med., 15 (9), 696–701.10.2459/JCM.000000000000012125000253
  32. Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., O’Brien, K. D. (1994). Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Circulation, 90 (2), 844–853.10.1161/01.CIR.90.2.844
  33. Pilmane, M., Rumba, I., Sundler, F., Luts, A. (1998). Patterns of distribution and occurrence of neuroendocrine elements in lungs of humans with chronic lung diseases. Proc. Latvian Acad. Sci., Section B, 52, 144–152.
  34. Sahinarslan, A., Vecchio, F., Maccarthy, P., Dworakowski, R., Deshpande, R. (2016). Dynamics of concomitant functional mitral regurgitation in patients with aortic stenosis undergoing TAVI. Acta Cardiol. Sin., 32 (4), 477–484.
  35. Schröder, J. M., Harder, J. (1999). Human beta-defensin-2. Int. J. Biochem. Cell Biol., 31 (6), 645–651.10.1016/S1357-2725(99)00013-8
  36. Selsted, M. E., Ouellette, A. J. (2005). Mammalian defensins in the antimicrobial immune response. Nature Immunol., 6 (6), 551–557.10.1038/ni1206
  37. Shubeitas, H. E., Mcdonough, P. M., Harris, A. N., Knowlton, K. U., Glembotskilll, C. C., Browns, J. H., Chien, K. R. (1990). Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J. Biol. Chem., 265 (33), 20555–20562.10.1016/S0021-9258(17)30538-0
  38. Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., Otto, C. M. (1997). Clinical factors associated with calcific aortic valve disease. J. Amer. Coll. Cardiol., 29 (3), 630–634.10.1016/S0735-1097(96)00563-3
  39. Sziksz, E., Pap, D., Lippai, R., Béres, N. J., Fekete, A., Szabó, A. J., Vannay, Á. (2015). Fibrosis related inflammatory mediators: Role of the IL-10 cytokine family. Mediators Inflamm., 2015, 1–15.10.1155/2015/764641449523126199463
  40. Tota, B., Angelone, T., Cerra, M. C. (2014). The surging role of Chromogranin A in cardiovascular homeostasis. Frontiers Chem., 2, 1–13.10.3389/fchem.2014.00064413226525177680
  41. Travin, M. I. (2017). Current clinical applications and next steps for cardiac innervation imaging. Curr. Cardiol. Rep., 19 (1), 28084596.10.1007/s11886-017-0817-228084596
  42. Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., Burns, R., Rayner, M., Townsend, N. (2017). European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels. 192 pp.
  43. Yasushi Matsuzawa, A. L. (2015). Endothelial dysfunction and coronary artery disease: Assessment, prognosis and treatment. Coron. Artery Dis., 25 (8), 713–724.
  44. Zimna, A., Kurpisz, M. (2015). Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: Applications and therapies. Biomed Res. Int., 2015, 549412.10.1155/2015/549412447126026146622
DOI: https://doi.org/10.2478/prolas-2021-0028 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 186 - 193
Submitted on: Nov 7, 2019
Accepted on: Feb 23, 2021
Published on: Jul 22, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2021 Edīte Vārtiņa, Māra Pilmane, Romāns Lācis, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.